Found: 17
Select item for more details and to access through your institution.
Medicinal cannabis for the treatment of anxiety disorders.
- Published in:
- Australian Journal of General Practice, 2022, v. 51, n. 8, p. 586
- By:
- Publication type:
- Article
Harmonised collection of data in youth mental health: Towards large datasets.
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2020, v. 54, n. 1, p. 46, doi. 10.1177/0004867419844322
- By:
- Publication type:
- Article
Assessment of Insulin Resistance Among Drug-Naive Patients With First-Episode Schizophrenia in the Context of Hormonal Stress Axis Activation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis.
- Published in:
- Translational Psychiatry, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41398-022-02217-0
- By:
- Publication type:
- Article
Trauma and posttraumatic stress disorder in transcultural patients with chronic pain.
- Published in:
- Neuropsychiatrie, 2014, v. 28, n. 4, p. 185, doi. 10.1007/s40211-014-0122-x
- By:
- Publication type:
- Article
Cortisol Awakening Response and Acute Stress Reactivity in First Nations People.
- Published in:
- Scientific Reports, 2017, p. 41760, doi. 10.1038/srep41760
- By:
- Publication type:
- Article
Screening for depression in young Indigenous people: building on a unique community initiative.
- Published in:
- Australian Journal of Primary Health, 2018, v. 24, n. 4, p. 343, doi. 10.1071/PY18006
- By:
- Publication type:
- Article
IGG ANTIBODIES TO TOXOPLASMA GONDII ARE ASSOCIATED WITH INCREASED LONG-TERM RISK FOR PSYCHOSIS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S141, doi. 10.1093/schbul/sbaa030.334
- By:
- Publication type:
- Article
THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S244, doi. 10.1093/schbul/sbaa029.594
- By:
- Publication type:
- Article
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.
- Published in:
- Frontiers in Psychiatry, 2019, p. N.PAG, doi. 10.3389/fpsyt.2019.00393
- By:
- Publication type:
- Article
A validated method for the simultaneous quantification of cannabidiol, Δ<sup>9</sup>‐tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open‐label trial.
- Published in:
- Drug Testing & Analysis, 2021, v. 13, n. 3, p. 614, doi. 10.1002/dta.2947
- By:
- Publication type:
- Article
Novel biotherapies are needed in youth mental health.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Allostatic load mediates the impact of stress and trauma on physical and mental health in Indigenous Australians.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Mental health consequences of stress and trauma: allostatic load markers for practice and policy with a focus on Indigenous health.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Acceptability and feasibility of a multidomain harmonized data collection protocol in youth mental health.
- Published in:
- Early Intervention in Psychiatry, 2023, v. 17, n. 5, p. 512, doi. 10.1111/eip.13346
- By:
- Publication type:
- Article
Cannabidiol for at risk for psychosis youth: A randomized controlled trial.
- Published in:
- Early Intervention in Psychiatry, 2022, v. 16, n. 4, p. 419, doi. 10.1111/eip.13182
- By:
- Publication type:
- Article
Omega‐3 fatty acids and neurocognitive ability in young people at ultra‐high risk for psychosis.
- Published in:
- Early Intervention in Psychiatry, 2021, v. 15, n. 4, p. 874, doi. 10.1111/eip.13025
- By:
- Publication type:
- Article